The Possible Role of Thyroxine in Keratoconus Development

NCT03637673 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-08-20

No results posted yet for this study

Summary

Keratoconus (KC) is a corneal ectatic disorders, with incidence rate 1 per 50,000 among the population. Hormonal imbalances may be associated with KC as it affects the corneal metabolism. In this study, we aim to examine this clinical association between thyroid gland dysfunction (TGD) and KC.

Conditions

  • Keratoconus

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2018-08-30
Completion
2018-09-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03637673 on ClinicalTrials.gov